SynthesisOpen biology2024
Genetic evidence for serum amyloid P component as a drug target in neurodegenerative disorders.
A Floriaan Schmidt et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this paperpooled itcites it